Switch to:
Also traded in: Denmark, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.13
WILYY's Cash to Debt is ranked lower than
92% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. WILYY: 0.13 )
Ranked among companies with meaningful Cash to Debt only.
WILYY' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.13 Max: No Debt
Current: 0.13
Equity to Asset 0.45
WILYY's Equity to Asset is ranked lower than
75% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. WILYY: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
WILYY' s Equity to Asset Range Over the Past 10 Years
Min: 0.11  Med: 0.27 Max: 0.5
Current: 0.45
0.11
0.5
Interest Coverage N/A
WILYY's Interest Coverage is ranked higher than
76% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 50.91 vs. WILYY: N/A )
Ranked among companies with meaningful Interest Coverage only.
WILYY' s Interest Coverage Range Over the Past 10 Years
Min: 7.22  Med: 15.99 Max: N/A
Current: N/A
F-Score: 7
Z-Score: 4.05
M-Score: -2.44
WACC vs ROIC
4.62%
15.56%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 17.61
WILYY's Operating margin (%) is ranked higher than
86% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. WILYY: 17.61 )
Ranked among companies with meaningful Operating margin (%) only.
WILYY' s Operating margin (%) Range Over the Past 10 Years
Min: 17.61  Med: 20.46 Max: 24.99
Current: 17.61
17.61
24.99
Net-margin (%) 13.46
WILYY's Net-margin (%) is ranked higher than
84% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.77 vs. WILYY: 13.46 )
Ranked among companies with meaningful Net-margin (%) only.
WILYY' s Net-margin (%) Range Over the Past 10 Years
Min: 12.7  Med: 14.21 Max: 17.71
Current: 13.46
12.7
17.71
ROE (%) 23.70
WILYY's ROE (%) is ranked higher than
93% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. WILYY: 23.70 )
Ranked among companies with meaningful ROE (%) only.
WILYY' s ROE (%) Range Over the Past 10 Years
Min: 23.76  Med: 47.25 Max: 164.41
Current: 23.7
23.76
164.41
ROA (%) 11.42
WILYY's ROA (%) is ranked higher than
88% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. WILYY: 11.42 )
Ranked among companies with meaningful ROA (%) only.
WILYY' s ROA (%) Range Over the Past 10 Years
Min: 11.21  Med: 16.97 Max: 29.89
Current: 11.42
11.21
29.89
ROC (Joel Greenblatt) (%) 50.18
WILYY's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. WILYY: 50.18 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WILYY' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 50.74  Med: 57.33 Max: 130.11
Current: 50.18
50.74
130.11
Revenue Growth (3Y)(%) 9.60
WILYY's Revenue Growth (3Y)(%) is ranked higher than
71% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. WILYY: 9.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WILYY' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 6.4  Med: 9.60 Max: 15.4
Current: 9.6
6.4
15.4
EBITDA Growth (3Y)(%) 11.50
WILYY's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. WILYY: 11.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WILYY' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.6  Med: 8.80 Max: 23.2
Current: 11.5
-1.6
23.2
EPS Growth (3Y)(%) 9.50
WILYY's EPS Growth (3Y)(%) is ranked higher than
58% of the 202 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. WILYY: 9.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WILYY' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.9  Med: 11.00 Max: 21
Current: 9.5
-1.9
21
» WILYY's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-14)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with WILYY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NYSE:MDT, NYSE:ABT, NYSE:SYK, NYSE:BSX, NYSE:ZBH, NAS:ISRG » details
Traded in other countries:WDH.Denmark, WDH1.Germany,
William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals.

William Demant Holding A/S is incorporated in Denmark. The Company is a hearing product and equipment manufacturer. The company operated in three segments namely Hearing Aids, Diagnostic Instruments, and Personal Communication. The Hearing Aid segment offers hearing aids under the Oticon and Bernafon brand names. Oticon offers several hearing aid lines, including EPOQ, Dual, Vigo, Hit, Sumo DM, and products for the elderly. Bernafon offers many hearing aid lines, including Verite, Icos, Brite, Move, Swissear, Symbio XT, Prio, Xtreme, Avanti, Neo, and Win. The products range from affordable to premium depending on the features needed. The Diagnostic Instruments segment includes Maico Diagnostics, Interacoustics, and Amplivox. Maico offers audiometers, middle ear analyzers, BERAphones, OAE test systems, software, and services. Interacoustics offer audiometers, middle ear analyzers, HA fitting, VNG balance systems, and rhiometry. Amplivox provides manual and automatic screening audiometers, audiogram software, diagnostic audiometers, acoustic booths, electro acoustic ear simulator, tympanometers, middle ear analyzers, spirometers, vision screeners, audiocups, and accessories and consumables. The Personal Communication segment operates under Phonic Ear and Sennheiser Communications. Phonic Ear offers sound field systems, teleloop and loudspeaker systems, infrared systems, and assistive listening devices.

Ratios

vs
industry
vs
history
P/E(ttm) 26.92
WILYY's P/E(ttm) is ranked higher than
50% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 25.75 vs. WILYY: 26.92 )
Ranked among companies with meaningful P/E(ttm) only.
WILYY' s P/E(ttm) Range Over the Past 10 Years
Min: 12.03  Med: 25.17 Max: 123.34
Current: 26.92
12.03
123.34
Forward P/E 22.57
WILYY's Forward P/E is ranked lower than
52% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 20.75 vs. WILYY: 22.57 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.92
WILYY's PE(NRI) is ranked higher than
52% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 26.67 vs. WILYY: 26.92 )
Ranked among companies with meaningful PE(NRI) only.
WILYY' s PE(NRI) Range Over the Past 10 Years
Min: 12.03  Med: 25.14 Max: 123.16
Current: 26.92
12.03
123.16
Price/Owner Earnings (ttm) 32.82
WILYY's Price/Owner Earnings (ttm) is ranked lower than
52% of the 113 Companies
in the Global Medical Devices industry.

( Industry Median: 30.78 vs. WILYY: 32.82 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
WILYY' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 12.33  Med: 31.41 Max: 314.88
Current: 32.82
12.33
314.88
P/B 5.89
WILYY's P/B is ranked lower than
78% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. WILYY: 5.89 )
Ranked among companies with meaningful P/B only.
WILYY' s P/B Range Over the Past 10 Years
Min: 4.26  Med: 11.10 Max: 70.24
Current: 5.89
4.26
70.24
P/S 3.63
WILYY's P/S is ranked lower than
54% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. WILYY: 3.63 )
Ranked among companies with meaningful P/S only.
WILYY' s P/S Range Over the Past 10 Years
Min: 1.91  Med: 3.61 Max: 17.66
Current: 3.63
1.91
17.66
PFCF 33.61
WILYY's PFCF is ranked lower than
57% of the 91 Companies
in the Global Medical Devices industry.

( Industry Median: 28.14 vs. WILYY: 33.61 )
Ranked among companies with meaningful PFCF only.
WILYY' s PFCF Range Over the Past 10 Years
Min: 15.28  Med: 32.12 Max: 220.93
Current: 33.61
15.28
220.93
POCF 24.30
WILYY's POCF is ranked lower than
57% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 19.95 vs. WILYY: 24.30 )
Ranked among companies with meaningful POCF only.
WILYY' s POCF Range Over the Past 10 Years
Min: 12.42  Med: 22.82 Max: 147.47
Current: 24.3
12.42
147.47
EV-to-EBIT 23.11
WILYY's EV-to-EBIT is ranked lower than
53% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.22 vs. WILYY: 23.11 )
Ranked among companies with meaningful EV-to-EBIT only.
WILYY' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.8  Med: 18.80 Max: 86.7
Current: 23.11
8.8
86.7
EV-to-EBITDA 19.65
WILYY's EV-to-EBITDA is ranked lower than
56% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 17.06 vs. WILYY: 19.65 )
Ranked among companies with meaningful EV-to-EBITDA only.
WILYY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.7  Med: 17.90 Max: 86.7
Current: 19.65
7.7
86.7
PEG 2.83
WILYY's PEG is ranked higher than
57% of the 72 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. WILYY: 2.83 )
Ranked among companies with meaningful PEG only.
WILYY' s PEG Range Over the Past 10 Years
Min: 0.66  Med: 2.62 Max: 43.99
Current: 2.83
0.66
43.99
Shiller P/E 36.45
WILYY's Shiller P/E is ranked higher than
60% of the 43 Companies
in the Global Medical Devices industry.

( Industry Median: 39.79 vs. WILYY: 36.45 )
Ranked among companies with meaningful Shiller P/E only.
WILYY' s Shiller P/E Range Over the Past 10 Years
Min: 23.92  Med: 30.32 Max: 36.74
Current: 36.45
23.92
36.74
Current Ratio 0.94
WILYY's Current Ratio is ranked lower than
91% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. WILYY: 0.94 )
Ranked among companies with meaningful Current Ratio only.
WILYY' s Current Ratio Range Over the Past 10 Years
Min: 0.78  Med: 0.99 Max: 1.82
Current: 0.94
0.78
1.82
Quick Ratio 0.68
WILYY's Quick Ratio is ranked lower than
90% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. WILYY: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
WILYY' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.69 Max: 1.06
Current: 0.68
0.52
1.06
Days Inventory 168.62
WILYY's Days Inventory is ranked lower than
64% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. WILYY: 168.62 )
Ranked among companies with meaningful Days Inventory only.
WILYY' s Days Inventory Range Over the Past 10 Years
Min: 155.09  Med: 167.69 Max: 243.7
Current: 168.62
155.09
243.7
Days Sales Outstanding 75.40
WILYY's Days Sales Outstanding is ranked lower than
55% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 69.05 vs. WILYY: 75.40 )
Ranked among companies with meaningful Days Sales Outstanding only.
WILYY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.71  Med: 75.12 Max: 85.21
Current: 75.4
64.71
85.21
Days Payable 64.04
WILYY's Days Payable is ranked higher than
52% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. WILYY: 64.04 )
Ranked among companies with meaningful Days Payable only.
WILYY' s Days Payable Range Over the Past 10 Years
Min: 48.58  Med: 58.41 Max: 82.47
Current: 64.04
48.58
82.47

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 73.32
WILYY's Price/Tangible Book is ranked lower than
98% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. WILYY: 73.32 )
Ranked among companies with meaningful Price/Tangible Book only.
WILYY' s Price/Tangible Book Range Over the Past 10 Years
Min: 16.14  Med: 30.54 Max: 174.43
Current: 73.32
16.14
174.43
Price/Projected FCF 2.22
WILYY's Price/Projected FCF is ranked lower than
51% of the 121 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. WILYY: 2.22 )
Ranked among companies with meaningful Price/Projected FCF only.
WILYY' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.6  Med: 2.11 Max: 13.2
Current: 2.22
1.6
13.2
Price/DCF (Earnings Based) 2.04
WILYY's Price/DCF (Earnings Based) is ranked higher than
53% of the 19 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. WILYY: 2.04 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.00
WILYY's Price/Median PS Value is ranked higher than
57% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. WILYY: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
WILYY' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.66  Med: 0.98 Max: 4.84
Current: 1
0.66
4.84
Price/Peter Lynch Fair Value 2.82
WILYY's Price/Peter Lynch Fair Value is ranked lower than
59% of the 44 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. WILYY: 2.82 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WILYY' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.3  Med: 2.03 Max: 4.44
Current: 2.82
0.3
4.44
Price/Graham Number 9.37
WILYY's Price/Graham Number is ranked lower than
93% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. WILYY: 9.37 )
Ranked among companies with meaningful Price/Graham Number only.
WILYY' s Price/Graham Number Range Over the Past 10 Years
Min: 3.75  Med: 5.97 Max: 30.72
Current: 9.37
3.75
30.72
Earnings Yield (Greenblatt) (%) 4.30
WILYY's Earnings Yield (Greenblatt) (%) is ranked higher than
73% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. WILYY: 4.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WILYY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.2  Med: 5.30 Max: 11.4
Current: 4.3
1.2
11.4
Forward Rate of Return (Yacktman) (%) 11.83
WILYY's Forward Rate of Return (Yacktman) (%) is ranked higher than
69% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 6.77 vs. WILYY: 11.83 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WILYY' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 3.3  Med: 11.95 Max: 27.8
Current: 11.83
3.3
27.8

More Statistics

Revenue (TTM) (Mil) $1,579
EPS (TTM) $ 0.16
Beta0.08
Short Percentage of Float0.00%
52-Week Range $14.92 - 22.22
Shares Outstanding (Mil)1,336.62

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 1,908 2,084
EPS ($) 0.22 1.24
EPS without NRI ($) 0.22 1.24
EPS Growth Rate
(3Y to 5Y Estimate)
12.36%

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)